EntryPoint Capital’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,311	Closed	-$101K	–	612
2024 Q2	$101K	Buy	+4,311	New	+$101K	0.15%	315
2024 Q1	–	Sell	-1,239	Closed	-$28.9K	–	1398
2023 Q4	$28.9K	Buy	+1,239	New	+$28.9K	0.03%	939